Perinatal Substance Use
NPA cares about pregnant and parenting people who are substance dependent and their babies. An emerging body of evidence tells us how to deliver timely and appropriate perinatal care for this population. But it requires collaboration across time, settings, and disciplines.
We believe that by working together we can improve the standard of care for these families and effect better outcomes. In 2015 the National Perinatal Association and our partners, National Advocates for Pregnant Women, hosted the symposium, Pregnant Women, Drug Use, and NAS: Experts Share Science & Strategies that Help Women, Babies, and Families.
We knew that in order to improve perinatal care and health policy we needed to bring together a diverse group of stakeholders. So we invited parents, providers, community leaders, policy makers, and family advocates to come together in search of interdisciplinary solutions.
In 2016 we convened the NPA Workgroup on Perinatal Substance Use with the goal of creating evidence-based, family-centered care recommendations for the support of drug using women and their families.
In 2018 we presented our work at our March conference
at Loma Linda University Children's Hospital in Loma Linda, California.